Investor Optimism Abounds Bluebird Bio, Inc. (NASDAQ:BLUE) But Growth Is Lacking

Simply Wall StDec 13 21:07

Trading Halt: Halted at 7:50:00 P.m. ET - Trading Halt: Halt News Pending

BenzingaDec 13 08:50

Bluebird Bio To Carry Out 1-for-20 Reverse Stock Split On December 13th, 2024

December 11th (Eastern Time) - $bluebird bio(BLUE.US)$ is about to implement a 1-for-20 reverse stock split of shares. The shares will begin trading on a split-adjusted basis from December 13th, 2024

Futu NewsDec 12 08:40

Reported Sunday, Bluebird Bio Highlights 9-Year Data For LYFGENIA Gene Therapy: Sustained Benefits In Sickle Cell Disease Patients At ASH 2024

BenzingaDec 9 15:48

Bluebird Bio Announced Long-Term Follow-Up Data Continue To Support Beti-Cel As Potentially Curative Gene Therapy For Β-Thalassemia Patients Who Require Regular Transfusions Through Achievement Of Durable Transfusion Independence And Normal Or...

BenzingaDec 8 04:30

12 Health Care Stocks Moving In Thursday's Pre-Market Session

BenzingaDec 6 05:05